Published in Medical Letter on the CDC and FDA, May 31st, 2006
Spine Wave expects to complete a StaXx XD limited U.S. release this summer with a broad market launch in the fall.
In January, Spine Wave closed a series C financing and raised an additional $36.5 million, bringing the total funds raised to date to $90 million.
The company is focused on the development and marketing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.